Govt expects states, UTs to add 8,000 more cold chain points (IANS Exclusive)
By IANS| Published: 17th December 2020 7:01 am IST
By Ashish Srivastava
New Delhi, Dec 16 : The cold storage network in the country is likely to reach 37,000 as states and Union territories are expected to raise at least 8,000 more cold chain points in the coming months as the country moves ahead with preparations for the COVID-19 vaccine rollout, a member of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) told IANS.
Currently, around 29,000 cold chain points are being drawing up for the mega COVID immunisation drive.
The member told IANS that the government had asked all states and UTs about the addition they would make to the existing network of cold chain storage units. “They informed us that provision for up to 8,000 cold chain points would be made by them in the coming months,” the member said.
Govt expects states, UTs to add 8,000 more cold chain points
By
Ashish Srivastava ( IANS) |
Published on
Wed, Dec 16 2020 19:42 IST |
3 Views
US states to start getting Covid-19 vaccine from Monday. Image Source: IANS News
New Delhi, Dec 16 : The cold storage network in the country is likely to reach 37,000 as states and Union territories are expected to raise at least 8,000 more cold chain points in the coming months as the country moves ahead with preparations for the COVID-19 vaccine rollout, a member of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) told IANS.
Currently, around 29,000 cold chain points are being drawing up for the mega COVID immunisation drive.
Another Indian COVID-19 vaccine candidate will start human trials soon
Pune-based Gennova Pharmaceuticals will start the phase 1 clinical trial of its indigenous vaccine candidate in January
(AFP)
Currently, the Indian regulators are considering three vaccines to authorise under emergency use
Share Via
Read Full Story
Dr VK Paul, Member of NITI Aayog, on Tuesday said the Drugs Controller General of India (DCGI) had recently granted clearance for an additional Covid-19 vaccine candidate from Gennova Pharmaceuticals Ltd. Gennova, in association with the Department of Biotechnology, a research agency under the government of India, has developed the vaccine. The technology used to develop this vaccine is same as the one used for the Pfizer vaccine, said Paul.